Figure 3
CR rate in AML patients. (A) CR rate according to FLT3/ITD status only and (B) CR rate according to FLT3/ITD and NUP98/NSD1 status. NSD1+ (NUP98/NSD1 present) NSD1− (NUP98/NSD1 absent); ITD+ (FLT3/ITD present); and ITD− (FLT3/ITD absent).
CR rate in AML patients. (A) CR rate according to FLT3/ITD status only and (B) CR rate according to FLT3/ITD and NUP98/NSD1 status. NSD1+ (NUP98/NSD1 present) NSD1− (NUP98/NSD1 absent); ITD+ (FLT3/ITD present); and ITD− (FLT3/ITD absent).
